Clinical Trial

Screening of Cancer Through Novel Female Specific Biomarkers

Study Description

Screening of Cancer Through Novel Female Specific Biomarkers

Can reliable biomarkers be identified for detection of cancer at early stages using menstrual blood (MB)? Preliminary mass spectrometry (MS) results suggest that MB provides biomarkers for identification of disease such as cancers.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Diagnostic Test - Menstrual Blood Screening Test

The sponsor will be testing women's menstrual blood to investigate the feasibility and efficacy of assessing three early stage cancers via self-collected menstrual blood using FDA approved devices.

Additional Information

Official Study Title

Screening and Early Detection of Cancer Through Identification of Novel Female Specific Biomarkers Through Self-Collected Menstrual Blood

Clinical Trial ID

NCT03951428

ParticipAid ID

e31PAb